These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9635544)

  • 1. The use of pindolol to potentiate antidepressant medication.
    Blier P; Bergeron R
    J Clin Psychiatry; 1998; 59 Suppl 5():16-23; discussion 24-5. PubMed ID: 9635544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation.
    Artigas F
    Arch Gen Psychiatry; 1995 Nov; 52(11):969-71. PubMed ID: 7487345
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interest of the use of pindolol in the treatment of depression: review].
    Brousse G; Schmitt A; Chereau I; Eschalier A; Dubray C; Llorca PM
    Encephale; 2003; 29(4 Pt 1):338-50. PubMed ID: 14615704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
    Blier P; Bergeron R; de Montigny C
    Neuropsychopharmacology; 1997 May; 16(5):333-8. PubMed ID: 9109104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of rapid-onset antidepressant treatment strategies.
    Blier P
    J Clin Psychiatry; 2001; 62 Suppl 15():12-7. PubMed ID: 11444761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.
    Nguyen KQ; Tohyama Y; Watanabe A; Hasegawa S; Skelin I; Diksic M
    Neurochem Int; 2009; 54(3-4):161-71. PubMed ID: 19073228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The augmentation hypothesis for improvement of antidepressant therapy: is pindolol a suitable candidate for testing the ability of 5HT1A receptor antagonists to enhance SSRI efficacy and onset latency?
    Kinney GG; Taber MT; Gribkoff VK
    Mol Neurobiol; 2000 Jun; 21(3):137-52. PubMed ID: 11379796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study.
    Gartside SE; Clifford EM; Cowen PJ; Sharp T
    Br J Pharmacol; 1999 May; 127(1):145-52. PubMed ID: 10369467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors.
    Artigas F; Perez V; Alvarez E
    Arch Gen Psychiatry; 1994 Mar; 51(3):248-51. PubMed ID: 8122960
    [No Abstract]   [Full Text] [Related]  

  • 10. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.
    Artigas F; Romero L; de Montigny C; Blier P
    Trends Neurosci; 1996 Sep; 19(9):378-83. PubMed ID: 8873352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
    Hjorth S; Auerbach SB
    Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the beneficial antidepressant effect of coadministration of pindolol really due to somatodendritic autoreceptor antagonism?
    Cremers TI; Wiersma LJ; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Biol Psychiatry; 2001 Jul; 50(1):13-21. PubMed ID: 11457419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
    Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
    Ann N Y Acad Sci; 1998 Dec; 861():204-16. PubMed ID: 9928258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.
    Martinez D; Hwang D; Mawlawi O; Slifstein M; Kent J; Simpson N; Parsey RV; Hashimoto T; Huang Y; Shinn A; Van Heertum R; Abi-Dargham A; Caltabiano S; Malizia A; Cowley H; Mann JJ; Laruelle M
    Neuropsychopharmacology; 2001 Mar; 24(3):209-29. PubMed ID: 11166513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC; Sanger DJ
    Eur J Pharmacol; 1999 May; 372(2):127-34. PubMed ID: 10395092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatodendritic action of pindolol to attenuate the paroxetine-induced decrease in serotonin release from the rat ventral hippocampus: a microdialysis study.
    Míguez JM; Paz-Valiñas L; Míguez I; Aldegunde M
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):378-87. PubMed ID: 12012024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo.
    Arborelius L; Linnér L; Wallsten C; Ahlenius S; Svensson TH
    Psychopharmacology (Berl); 2000 Jul; 151(1):77-84. PubMed ID: 10958120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.
    Pérez V; Soler J; Puigdemont D; Alvarez E; Artigas F
    Arch Gen Psychiatry; 1999 Apr; 56(4):375-9. PubMed ID: 10197835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
    Béïque JC; Blier P; de Montigny C; Debonnel G
    Neuropsychopharmacology; 2000 Sep; 23(3):294-306. PubMed ID: 10942853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study.
    Berney A; Nishikawa M; Benkelfat C; Debonnel G; Gobbi G; Diksic M
    Neurochem Int; 2008; 52(4-5):701-8. PubMed ID: 17928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.